
Drug maker Indivior has become the latest major UK listed company to scrap its London share trading.
The pharmaceuticals company, which has its UK headquarters in Slough, said it planned to cancel its secondary listing in London.

Drug maker Indivior has become the latest major UK listed company to scrap its London share trading.
The pharmaceuticals company, which has its UK headquarters in Slough, said it planned to cancel its secondary listing in London.